{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:19:28Z","timestamp":1785226768233,"version":"3.55.0"},"reference-count":20,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T00:00:00Z","timestamp":1453334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T00:00:00Z","timestamp":1453334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Blood Cancer"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1002\/pbc.25893","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T16:22:25Z","timestamp":1453393345000},"page":"901-907","source":"Crossref","is-referenced-by-count":10,"title":["Resource Utilization and Toxicities After Carboplatin\/Etoposide\/Melphalan and Busulfan\/Melphalan for Autologous Stem Cell Rescue in High-Risk Neuroblastoma Using a National Administrative Database"],"prefix":"10.1002","volume":"63","author":[{"given":"Ami V.","family":"Desai","sequence":"first","affiliation":[{"name":"Division of Oncology; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania"},{"name":"Department of Pediatrics; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alix E.","family":"Seif","sequence":"additional","affiliation":[{"name":"Division of Oncology; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania"},{"name":"Department of Pediatrics; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania"},{"name":"Department of Pediatrics; Perelman School of Medicine at the University of Pennsylvania; Philadelphia Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimei","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Oncology; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania"},{"name":"Department of Pediatrics; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania"},{"name":"Department of Pediatrics; Perelman School of Medicine at the University of Pennsylvania; Philadelphia Pennsylvania"},{"name":"Center for Clinical Epidemiology and Biostatistics; Perelman School of Medicine at the University of Pennsylvania; Philadelphia Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Getz","sequence":"additional","affiliation":[{"name":"Division of Oncology; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania"},{"name":"Department of Pediatrics; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Fisher","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania"},{"name":"Department of Pediatrics; Perelman School of Medicine at the University of Pennsylvania; Philadelphia Pennsylvania"},{"name":"Center for Clinical Epidemiology and Biostatistics; Perelman School of Medicine at the University of Pennsylvania; Philadelphia Pennsylvania"},{"name":"Division of Infectious Diseases; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania"},{"name":"Center for Pediatric Clinical Effectiveness; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania"},{"name":"Center for Pediatric Clinical Effectiveness; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adjoa","family":"Mante","sequence":"additional","affiliation":[{"name":"Division of Oncology; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Aplenc","sequence":"additional","affiliation":[{"name":"Division of Oncology; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania"},{"name":"Department of Pediatrics; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania"},{"name":"Department of Pediatrics; Perelman School of Medicine at the University of Pennsylvania; Philadelphia Pennsylvania"},{"name":"Center for Clinical Epidemiology and Biostatistics; Perelman School of Medicine at the University of Pennsylvania; Philadelphia Pennsylvania"},{"name":"Center for Pediatric Clinical Effectiveness; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle","family":"Bagatell","sequence":"additional","affiliation":[{"name":"Division of Oncology; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania"},{"name":"Department of Pediatrics; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania"},{"name":"Department of Pediatrics; Perelman School of Medicine at the University of Pennsylvania; Philadelphia Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,1,21]]},"reference":[{"key":"10.1002\/pbc.25893-BIB0001|pbc25893-cit-0001","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1200\/JCO.2007.13.8925","article-title":"Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: A children's oncology group study","volume":"27","author":"Matthay","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.25893-BIB0002|pbc25893-cit-0002","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2011.29.18_suppl.2","article-title":"Busulphan-melphalan as a myeloablative therapy (MAT) for high-risk neuroblastoma: Results from the HR-NBL1\/SIOPEN trial","volume":"29","author":"Ladenstein","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.25893-BIB0003|pbc25893-cit-0003","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/pbc.25475","article-title":"Comparison of administrative\/billing data to expected protocol-mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group","volume":"62","author":"Miller","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1002\/pbc.25893-BIB0004|pbc25893-cit-0004","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/cncr.27957","article-title":"Induction mortality and resource utilization in children treated for acute myeloid leukemia at free-standing pediatric hospitals in the United States","volume":"119","author":"Kavcic","year":"2013","journal-title":"Cancer"},{"key":"10.1002\/pbc.25893-BIB0005|pbc25893-cit-0005","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/pbc.24930","article-title":"Establishing a high-risk neuroblastoma cohort using the pediatric health information system database","volume":"61","author":"Desai","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1002\/pbc.25893-BIB0006|pbc25893-cit-0006","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa0911123","article-title":"Children's Oncology Group. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma","volume":"363","author":"Yu","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1002\/pbc.25893-BIB0007|pbc25893-cit-0007","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/PCC.0000000000000042","article-title":"Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United States","volume":"15","author":"Maude","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"10.1002\/pbc.25893-BIB0008|pbc25893-cit-0008","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/bmt.2015.52","article-title":"Sinusoidal obstruction syndrome\/veno-occlusive disease: Current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)","volume":"50","author":"Mohty","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.25893-BIB0009|pbc25893-cit-0009","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S1470-2045(13)70309-7","article-title":"Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): A randomised phase 3 trial","volume":"14","author":"Kreissman","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1002\/pbc.25893-BIB0010|pbc25893-cit-0010","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.bbmt.2013.07.017","article-title":"Pulmonary hypertension after hematopoietic stem cell transplantation","volume":"19","author":"Dandoy","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1002\/pbc.25893-BIB0011|pbc25893-cit-0011","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bbmt.2012.08.022","article-title":"Pulmonary arterial hypertension in pediatric patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"19","author":"Jodele","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1002\/pbc.25893-BIB0012|pbc25893-cit-0012","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12185-012-1246-z","article-title":"Successful treatment of pulmonary hypertension with beraprost and sildenafil after cord blood transplantation for infantile leukemia","volume":"97","author":"Kawashima","year":"2013","journal-title":"Int J Hematol"},{"key":"10.1002\/pbc.25893-BIB0013|pbc25893-cit-0013","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/pbc.24405","article-title":"Pulmonary hypertension following haematopoietic stem cell transplantation for primary haemophagocytic lymphohistiocytosis","volume":"60","author":"Zeilhofer","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1002\/pbc.25893-BIB0014|pbc25893-cit-0014","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3109\/10428194.2012.661052","article-title":"Clinicopathologic features of late-onset veno-occlusive disease\/sinusoidal obstruction syndrome after high dose intravenous busulfan and hematopoietic cell transplant","volume":"53","author":"Pai","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1002\/pbc.25893-BIB0015|pbc25893-cit-0015","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.bbmt.2007.08.002","article-title":"Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients","volume":"13","author":"Carreras","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1002\/pbc.25893-BIB0016|pbc25893-cit-0016","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.bmt.1701994","article-title":"Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation","volume":"24","author":"Toh","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.25893-BIB0017|pbc25893-cit-0017","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1016\/j.ejca.2012.05.020","article-title":"Busulfan pharmacokinetics following intravenous and oral dosing regimens in children receiving high-dose myeloablative chemotherapy for high-risk neuroblastoma as part of the HR-NBL-1\/SIOPEN trial","volume":"48","author":"Veal","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1002\/pbc.25893-BIB0018|pbc25893-cit-0018","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.264","article-title":"Tandem high-dose chemotherapy with thiotepa and busulfan-melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients","author":"Pasqualini","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.25893-BIB0019|pbc25893-cit-0019","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/sj.bmt.1702376","article-title":"Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma","volume":"25","author":"Valteau-Couanet","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.25893-BIB0020|pbc25893-cit-0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/petr.12202","article-title":"Busulfan and melphalan as consolidation therapy with autologous peripheral blood stem cell transplantation following Children's Oncology Group (COG) induction platform for high-risk neuroblastoma: early results from a single institution","volume":"18","author":"Soni","year":"2014","journal-title":"Pediatr Transplant"}],"container-title":["Pediatric Blood & Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.25893","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.25893","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/pbc.25893\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T04:12:50Z","timestamp":1498277570000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/pbc.25893"}},"subtitle":["Resource Utilization for Stem Cell Rescue in NBL"],"short-title":[],"issued":{"date-parts":[[2016,1,21]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"URL":"https:\/\/doi.org\/10.1002\/pbc.25893","archive":["Portico"],"relation":{},"ISSN":["1545-5009"],"issn-type":[{"value":"1545-5009","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1,21]]}}}